{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T03:59:32Z","timestamp":1772164772071,"version":"3.50.1"},"reference-count":12,"publisher":"American Association for Cancer Research (AACR)","issue":"7","license":[{"start":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T00:00:00Z","timestamp":1719187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014491","name":"Allergan | Pharmacyclics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100021316","name":"AstraZeneca United States","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017655","name":"Incyte","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017655","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014481","name":"Gilead | Kite Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014481","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Cancer-related fatigue (CRF) continues to be a challenging phenomenon that is often underreported and poorly understood. With etiologies in both disease and treatment manifesting as a symptom and a side effect, respectively, CRF is highly incident and presents a significant clinical problem that impacts survivorship. We conducted a survey to ascertain the patient-reported incidence of symptoms and side effects for people with lymphoma or chronic lymphocytic leukemia. We found that CRF was enhanced in those who received more intense therapies that coincided with more aggressive lymphoma subtypes. These data illuminate an unmet need among patients with lymphoma and provide an opportunity to further refine treatment regimens in order to reduce the burden of CRF in this vulnerable population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>CRF is a highly incident phenomenon in lymphoma that can be ascribed to a combination of causes. We have demonstrated substantial variability across various subtypes of lymphoma and have estimated that nearly half of the reported fatigue comes from treatment. Increased screening for and monitoring of fatigue will yield favorable health-related quality of life that will benefit health technology assessment activities and yield improved outcomes for patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-24-0048","type":"journal-article","created":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T12:45:41Z","timestamp":1717591541000},"page":"1620-1624","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cancer-Related Fatigue and the Additive Effect of Treatment in the Context of Lymphoma: An Analysis of the Lymphoma Coalition\u2019s 2022 Global Patient Survey"],"prefix":"10.1158","volume":"4","author":[{"given":"Steve E.","family":"Kalloger","sequence":"first","affiliation":[{"name":"Lymphoma Coalition, Mississauga, Canada. 1"},{"name":"Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada. 2"},{"name":"School of Population and Public Health, University of British Columbia, Vancouver, Canada. 3"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Watson","sequence":"additional","affiliation":[{"name":"Lymphoma Coalition, Mississauga, Canada. 1"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shawn","family":"Sajkowski","sequence":"additional","affiliation":[{"name":"Lymphoma Coalition, Mississauga, Canada. 1"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorna","family":"Warwick","sequence":"additional","affiliation":[{"name":"Lymphoma Coalition, Mississauga, Canada. 1"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2024,7,1]]},"reference":[{"key":"2024082201175432400_bib1","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1002\/cncr.23448","article-title":"Physical and psychological long-term and late effects of cancer","volume":"112","author":"Stein","year":"2008","journal-title":"Cancer"},{"key":"2024082201175432400_bib2","first-page":"1319","article-title":"Clinical factors associated with cancer-related fatigue in patients being treated for leukemia and non-Hodgkin\u2019s lymphoma","volume":"20","author":"Wang","year":"2002","journal-title":"J Clin Oncol"},{"key":"2024082201175432400_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1188\/08.CJON.S2.11-20","article-title":"Pathophysiology of cancer-related fatigue","volume":"12","author":"Wang","year":"2008","journal-title":"Clin J Oncol Nurs"},{"key":"2024082201175432400_bib4","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S0033-3182(09)70835-7","article-title":"Cancer-related fatigue and its associations with depression and anxiety: a systematic review","volume":"50","author":"Brown","year":"2009","journal-title":"Psychosomatics"},{"key":"2024082201175432400_bib5","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s11136-015-1217-y","article-title":"QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30","volume":"25","author":"King","year":"2016","journal-title":"Qual Life Res"},{"key":"2024082201175432400_bib6","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jval.2019.01.001","article-title":"Health technology assessment challenges in oncology: 20 years of value in health","volume":"22","author":"Kim","year":"2019","journal-title":"Value Health"},{"key":"2024082201175432400_bib7","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.annonc.2020.02.016","article-title":"Cancer-related fatigue: ESMO clinical practice guidelines for diagnosis and treatment","volume":"31","author":"Fabi","year":"2020","journal-title":"Ann Oncol"},{"key":"2024082201175432400_bib8","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/S0959-8049(03)00545-8","article-title":"Fatigue in long-term survivors of Hodgkin\u2019s lymphoma; a report from the German Hodgkin Lymphoma Study Group (GHSG)","volume":"39","author":"R\u00fcffer","year":"2003","journal-title":"Eur J Cancer"},{"key":"2024082201175432400_bib9","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1002\/cncr.28058","article-title":"Cancer-related fatigue and its impact on functioning","volume":"119 Suppl 11","author":"Minton","year":"2013","journal-title":"Cancer"},{"key":"2024082201175432400_bib10","doi-asserted-by":"crossref","first-page":"e0130023","DOI":"10.1371\/journal.pone.0130023","article-title":"Fatigue as a driver of overall quality of life in cancer patients","volume":"10","author":"McCabe","year":"2015","journal-title":"PLoS One"},{"key":"2024082201175432400_bib11","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.6004\/jnccn.2015.0122","article-title":"Cancer-related fatigue clinical practice guidelines in oncology NCCN clinical practice guidelines in oncology on cancer-related fatigue","volume":"13","author":"Berger","year":"2010","journal-title":"J Natl Compr Cancer Netw"},{"key":"2024082201175432400_bib12","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1200\/JCO.2013.53.4495","article-title":"Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical Oncology clinical practice guideline adaptation","volume":"32","author":"Bower","year":"2014","journal-title":"J Clin Oncol"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-24-0048\/3460121\/crc-24-0048.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/4\/7\/1620\/3487989\/crc-24-0048.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/4\/7\/1620\/3487989\/crc-24-0048.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T21:24:24Z","timestamp":1724275464000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/4\/7\/1620\/746044\/Cancer-Related-Fatigue-and-the-Additive-Effect-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,1]]},"references-count":12,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-24-0048","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.26090295","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26090298","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26090286","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26090292.v2","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26090292","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26090292.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26142330","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26142330.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26090286.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26090289","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26090289.v2","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26090289.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26798537.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26090295.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26798537","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26090295.v2","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26090298.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26090298.v2","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.7299441","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.c.7299441.v2","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.c.7299441.v1","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,1]]}}}